(Q34982751)

English

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

0 references

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials (English)

1 reference

Europe PubMed Central

5 August 2017

0 references

0 references

0 references

circulatory system

1 reference

based on heuristic

inferred from title

object named as

David Preiss

6

0 references

8

object named as

Naveed Sattar

1 reference

Europe PubMed Central

5 August 2017

author name string

Kausik K Ray

1

1 reference

Europe PubMed Central

5 August 2017

Sreenivasa Rao Kondapally Seshasai

2

1 reference

Europe PubMed Central

5 August 2017

Shanelle Wijesuriya

3

1 reference

Europe PubMed Central

5 August 2017

Rupa Sivakumaran

4

1 reference

Europe PubMed Central

5 August 2017

Sarah Nethercott

5

1 reference

Europe PubMed Central

5 August 2017

Sebhat Erqou

7

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

1 May 2009

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

373

1 reference

Europe PubMed Central

5 August 2017

9677

1 reference

Europe PubMed Central

5 August 2017

1765-1772

1 reference

Europe PubMed Central

5 August 2017

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The University Group Diabetes Program. A statistician looks at the mortality results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of a multifactorial intervention on mortality in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Achilles heel of the University Group Diabetes Program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tight control of blood glucose in long standing type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960697-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)60697-8

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34982751&oldid=1565191921"